Table of Contents
Cover image

FEATURED ARTICLE
Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care. Simon Cherry et al. See page 3.
Validation of 2-18F-Fluorodeoxysorbitol as a Potential Radiopharmaceutical for Imaging Bacterial Infection in the Lung. Junling Li et al. See page 134.
Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies. Neeta Pandit-Taskar et al. See page 147.